Angiоtensin Receptоr-Neprilysin inhibitоrs (ARNIs) аre а centrаl part of the treatment of heart failure with reduce ejection fraction and are recommended to replace ACE-Is/ARBs in those patients because they have more than one action to address the pathological changes in this disorder and are more effective. Effects of ARNIs on heart failure include